Sensitive liquid chromatography tandem mass spectrometry method for the quantification of Quetiapine in plasma.
A sensitive high-performance liquid chromatography-tandem mass spectrometry method was developed and validated for the quantification of quetiapine in rat plasma. Following liquid-liquid extraction, the analyte was separated using a gradient mobile phase on a reverse-phase column and analyzed by MS/MS in the multiple reaction monitoring mode using the respective [M + H]+ ions, m/z 384 to m/z 221 for quetiapine and m/z 327 to m/z 270 for the internal standard. The assay exhibited a linear dynamic range of 0.25-500 ng/mL for quetiapine in rat plasma. The lower limit of quantification was 0.25 ng/mL with a relative standard deviation of less than 7%. Acceptable precision and accuracy were obtained for concentrations over the standard curve range. The validated method was successfully used to analyze rat plasma samples for application in pre-clinical pharmacokinetic studies. This method in rodent plasma could be adapted for quetiapine assay in human plasma.
Nirogi
Ramakrishna
R
Pharmacokinetics and Drug Metabolism, Drug Discovery, Suven Life Sciences Ltd, Serene Chambers, Road 5, Avenue 7, Banjara Hills, Hyderabad 500034, India. ramakrishna_nirogi@yahoo.co.in
Bhyrapuneni
Gopinadh
G
Kandikere
Vishwottam
V
Mudigonda
Koteshwara
K
Ajjala
Devender
D
Mukkanti
K
K
D000818:Animals; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D003987:Dibenzothiazepines / Q000097:blood*; D000069348:Quetiapine Fumarate; D051381:Rats; D017208:Rats, Wistar; D015203:Reproducibility of Results; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods; D053719:Tandem Mass Spectrometry / Q000379:methods*
D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate